Biblio Discovery — Demo Discovery Service

19 hasil untuk "Rob Fijnheer"

Menampilkan 1–19 · 0,25 detik · RSS

  1. Artikel Jurnal

    Fatal cerebral hemorrhage in a patient with thrombotic thrombocytopenic purpura with a normal platelet count during treatment with caplacizumab

    Kim Ditzel; Dirk Jan Mons; Rob Fijnheer

    Platelets, Vol. 33 No. 3 · 2022 · Inggris · DOAJ Scopus

    Acquired thrombotic thrombocytopenic purpura (aTTP) is a thrombotic microangiopathy with a severe mortality and morbidity. Caplacizumab has recently been approved in the Netherlands as a new therapeutic option in patients with life-threatening organ failure due to aTTP. We describe the case of a 50…

  2. Artikel Jurnal

    Disappearing acts of ADAMTS13

    Jan Voorberg; Fabian C. Verbij; Rob Fijnheer

    EBioMedicine, Vol. 2 No. 8 · 2015 · Inggris · DOAJ Scopus

  3. Artikel Jurnal

    Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

    Wouter Pos; Nicoletta Sorvillo; Rob Fijnheer dkk.

    Haematologica, Vol. 96 No. 11 · 2011 · Inggris · DOAJ Scopus

    Background The majority of patients diagnosed with thrombotic thrombocytopenic purpura have autoantibodies directed towards the spacer domain of ADAMTS13.Design and Methods In this study we explored the epitope specificity and immunoglobulin class and immunoglobulin G subclass distribution of…

  4. Artikel Jurnal Teks lengkap

    Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers

    Judith Brouwers; Rintis Noviyanti; Rob Fijnheer dkk.

    PLoS ONE, Vol. 8 No. 6 · 2013 · Inggris · PLOS Scopus

    Introduction: The angiogenic proteins angiopoietin (Ang)-1, Ang-2 and vascular endothelial growth factor (VEGF) are regulators of endothelial inflammation and integrity. Since platelets store large amounts of Ang-1 and VEGF, measurement of circulation levels of these proteins is sensitive to…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98%

    Romy de Laat-Kremers; Raf De Jongh; Marisa Ninivaggi dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Thrombosis is a major clinical complication of COVID-19 infection. COVID-19 patients show changes in coagulation factors that indicate an important role for the coagulation system in the pathogenesis of COVID-19. However, the multifactorial nature of thrombosis complicates the prediction of…

  6. Artikel Jurnal

    Von Willebrand factor, ADAMTS13 and mortality in dialysis patients

    Gurbey Ocak; Mark Roest; Marianne C. Verhaar dkk.

    BMC Nephrology, Vol. 22 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Von Willebrand Factor (VWF) multimers are cleaved into smaller and less coagulant forms by the metalloprotease ADAMTS13. The aim of this study was to investigate the association between VWF and ADAMTS13 and mortality in dialysis patients. Methods We prospectively followed 956…

  7. Artikel Jurnal Teks lengkap

    Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13

    Kis Djamiatun; Andre J. A. M. van der Ven; Philip G. de Groot dkk.

    PLoS Neglected Tropical Diseases, Vol. 6 No. 5 · 2012 · Inggris · PLOS Scopus

    Background: Thrombocytopenia, bleeding and plasma leakage are cardinal features of severe dengue. Endothelial cell activation with exocytosis of Weibel-Palade bodies (WPBs) may play an etiological role in this condition. Methods and Principal Findings: In a cohort of 73 Indonesian children with…

    Juga tersedia di: DOAJ

  8. Artikel Jurnal

    Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients

    An-Sofie Schelpe; Elien Roose; Bérangère S. Joly dkk.

    Haematologica, Vol. 104 No. 6 · 2019 · Inggris · DOAJ Scopus

    In autoantibody-mediated autoimmune diseases, autoantibody profiling allows patients to be stratified and links autoantibodies with disease severity and outcome. However, in immune-mediated thrombotic thrombocytopenic purpura (iTTP) patients, stratification according to antibody profiles and their…

  9. Artikel Jurnal Teks lengkap

    Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET)

    Barend M. Mol; Maarten C. Verwer; Rob Fijnheer dkk.

    PLoS ONE, Vol. 19 No. 5 · 2024 · Inggris · DOAJ Scopus

    Introduction: The risk of major bleeding complications in catheter directed thrombolysis (CDT) for acute limb ischemia (ALI) remains high, with reported major bleeding complication rates in up to 1 in every 10 treated patients. Fibrinogen was the only predictive marker used for bleeding…

    Juga tersedia di: PLOS, DOAJ

  10. Artikel Jurnal

    Patients With Multiple Myeloma Have a Disbalanced Whole Blood Thrombin Generation Profile

    Li Li; Mark Roest; Yaqiu Sang dkk.

    Frontiers in Cardiovascular Medicine, Vol. 9 · 2022 · Inggris · DOAJ Scopus

    BackgroundMultiple myeloma (MM) is associated with a high prevalence of bleeding and an increased risk of thrombo-embolism. MM patients have reduced platelet- and red blood cell (RBC) numbers in blood, which may indicate that the paradoxical hemostasis profile is a consequence of a disturbed…

  11. Artikel Jurnal

    The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages

    Fabian C. Verbij; Nicoletta Sorvillo; Paul H.P. Kaijen dkk.

    Blood Advances, Vol. 1 No. 5 · 2017 · Inggris · DOAJ Scopus

    Abstract: Internalization of ADAMTS13 by macrophages may contribute to its clearance from the circulation. Here we investigated endocytic mechanisms that contribute to the uptake of ADAMTS13 by macrophages. Human monocyte-derived macrophages were used to monitor the uptake of fluorescently labeled…

  12. Artikel Jurnal

    Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study

    Marie José Kersten; Martin Dreyling; Kim M. Linton dkk.

    Haematologica, Vol. 999 No. 1 · 2026 · Inggris · DOAJ Scopus

    The R2 (lenalidomide-rituximab) and R2 with bendamustine (R2B) regimens are both feasible in relapsed/refractory follicular lymphoma (R/R FL), but prospective phase II data on R2B are lacking. In this multinational, prospective, randomised, non-comparative trial, patients with R/R FL were…

  13. Artikel Jurnal

    Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP

    Marcel Nijland; Djamila E. Issa; Johanna A. A. Bult dkk.

    Blood Advances, Vol. 9 No. 14 · 2025 · Inggris · DOAJ Scopus

    Abstract: The risk of relapse among high-risk patients with diffuse large B-cell lymphoma (DLBCL) in complete metabolic remission (CMR) after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy is 20% to 25%. Here, we evaluated whether consolidation with the…